Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic cancer vaccines: current status and perspectives
Luigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy (2012) Vol. 12, Iss. 8, pp. 1043-1058
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 613
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee, Elliot S. Bishop, Ruyi Zhang, et al.
Genes & Diseases (2017) Vol. 4, Iss. 2, pp. 43-63
Open Access | Times Cited: 599
Therapeutic cancer vaccines: past, present, and future.
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 559
Adenovirus: The First EffectiveIn VivoGene Delivery Vector
Ronald G. Crystal
Human Gene Therapy (2014) Vol. 25, Iss. 1, pp. 3-11
Open Access | Times Cited: 304
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari, Michele Graciotti, Michal Bassani‐Sternberg, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 635-652
Closed Access | Times Cited: 225
Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
Yuka Igarashi, Tetsuro Sasada
Journal of Immunology Research (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 156
Mechanism of Action of Immunotherapy
Mary L. Disis
Seminars in Oncology (2014) Vol. 41, pp. S3-S13
Open Access | Times Cited: 149
Antigen-specific vaccines for cancer treatment
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145
Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells
Ignazio Maggio, Maarten Holkers, Jin Liu, et al.
Scientific Reports (2014) Vol. 4, Iss. 1
Open Access | Times Cited: 134
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
Ren-You Pan, Wen‐Hung Chung, Mu-Tzu Chu, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 115
Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
Stefania Lanzardo, Laura Conti, Ronald Rooke, et al.
Cancer Research (2015) Vol. 76, Iss. 1, pp. 62-72
Open Access | Times Cited: 109
Therapeutic cancer vaccines: From initial findings to prospects
Qian Song, Cheng-dong Zhang, Xianghua Wu
Immunology Letters (2018) Vol. 196, pp. 11-21
Closed Access | Times Cited: 93
Immunotherapy of cancers comes of age
Hila Yousefi, Jianda Yuan, Mahsa Keshavarz‐Fathi, et al.
Expert Review of Clinical Immunology (2017) Vol. 13, Iss. 10, pp. 1001-1015
Closed Access | Times Cited: 92
Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
Brennetta J. Crenshaw, Leandra B. Jones, Courtnee’ R. Bell, et al.
Biomedicines (2019) Vol. 7, Iss. 3, pp. 61-61
Open Access | Times Cited: 88
Ultrasound in tumor immunotherapy: Current status and future developments
Yi-Ju Ho, Ju-Pi Li, Ching‐Hsiang Fan, et al.
Journal of Controlled Release (2020) Vol. 323, pp. 12-23
Closed Access | Times Cited: 75
Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
Xiaoxue Lang, Xiangtao Wang, Meihua Han, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4533-4568
Open Access | Times Cited: 9
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa, et al.
Pharmacology & Therapeutics (2016) Vol. 165, pp. 32-49
Closed Access | Times Cited: 80
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
Claudia Marcela Diaz, Alberto Chiappori, Luigi Aurisicchio, et al.
Journal of Translational Medicine (2013) Vol. 11, Iss. 1
Open Access | Times Cited: 76
Electrical Stimulation for Immune Modulation in Cancer Treatments
Ritopa Das, Sofia Langou, Thinh T. Le, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 32
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6
Cancer Vaccines in Ovarian Cancer: How Can We Improve?
Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, et al.
Biomedicines (2016) Vol. 4, Iss. 2, pp. 10-10
Open Access | Times Cited: 55
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
Roberto Ruiu, Lidia Tarone, Valeria Rolih, et al.
Progress in molecular biology and translational science (2019), pp. 119-188
Closed Access | Times Cited: 46
Safety and Efficacy of a Genetic Vaccine Targeting Telomerase Plus Chemotherapy for the Therapy of Canine B-Cell Lymphoma
Alessandra Gavazza, George Lubas, Arthur Fridman, et al.
Human Gene Therapy (2013) Vol. 24, Iss. 8, pp. 728-738
Open Access | Times Cited: 53
Large‐scale adenovirus and poxvirus‐vectored vaccine manufacturing to enable clinical trials
Héla Kallel, Amine Kamen
Biotechnology Journal (2015) Vol. 10, Iss. 5, pp. 741-747
Closed Access | Times Cited: 48
Therapeutic gene modified cell based cancer vaccines
Anna Kozłowska, Jacek Mackiewicz, Andrzej Maćkiewicz
Gene (2013) Vol. 525, Iss. 2, pp. 200-207
Closed Access | Times Cited: 47
Page 1 - Next Page

Scroll to top